These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33971274)

  • 1. Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study.
    Preisig D; Varum F; Bravo R; Hartig C; Spleiss J; Abbes S; Caobelli F; Wild D; Puchkov M; Huwyler J; Haschke M
    Eur J Pharm Biopharm; 2021 Aug; 165():22-30. PubMed ID: 33971274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scintigraphic evaluation of a new capsule-type colon specific drug delivery system in healthy volunteers.
    Ishibashi T; Pitcairn GR; Yoshino H; Mizobe M; Wilding IR
    J Pharm Sci; 1998 May; 87(5):531-5. PubMed ID: 9572900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are chitosan formulations mucoadhesive in the human small intestine? An evaluation based on gamma scintigraphy.
    Säkkinen M; Marvola J; Kanerva H; Lindevall K; Ahonen A; Marvola M
    Int J Pharm; 2006 Jan; 307(2):285-91. PubMed ID: 16310992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation.
    Kenyon CJ; Nardi RV; Wong D; Hooper G; Wilding IR; Friend DR
    Aliment Pharmacol Ther; 1997 Feb; 11(1):205-13. PubMed ID: 9042995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis.
    Krishnaiah YS; Bhaskar Reddy PR; Satyanarayana V; Karthikeyan RS
    Int J Pharm; 2002 Apr; 236(1-2):43-55. PubMed ID: 11891069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI.
    Sager M; Grimm M; Aude P; Schick P; Merdivan S; Hasan M; Kromrey ML; Sivert A; Benameur H; Koziolek M; Tzvetkov MV; Weitschies W
    J Control Release; 2019 Nov; 313():24-32. PubMed ID: 31626859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactoferrin-Loaded Alginate Microparticles to Target Clostridioides difficile Infection.
    Braim S; Śpiewak K; Brindell M; Heeg D; Alexander C; Monaghan T
    J Pharm Sci; 2019 Jul; 108(7):2438-2446. PubMed ID: 30851342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets.
    Maurer JM; Schellekens RC; van Rieke HM; Wanke C; Iordanov V; Stellaard F; Wutzke KD; Dijkstra G; van der Zee M; Woerdenbag HJ; Frijlink HW; Kosterink JG
    PLoS One; 2015; 10(7):e0129076. PubMed ID: 26177019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
    Marvola T; Marvola J; Kanerva H; Ahonen A; Lindevall K; Marvola M
    Int J Pharm; 2008 Feb; 349(1-2):24-9. PubMed ID: 17869037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
    Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
    World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release.
    Foppoli A; Maroni A; Moutaharrik S; Melocchi A; Zema L; Palugan L; Cerea M; Gazzaniga A
    Int J Pharm; 2019 Dec; 572():118723. PubMed ID: 31628978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole loaded pectin microspheres for colon targeting.
    Vaidya A; Jain A; Khare P; Agrawal RK; Jain SK
    J Pharm Sci; 2009 Nov; 98(11):4229-36. PubMed ID: 19492406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Application of MRI and the Salivary Tracer Technique to Determine the in Vivo Disintegration Time of Immediate Release Formulation Administered to Healthy, Fasted Subjects.
    Sager M; Grimm M; Jedamzik P; Merdivan S; Kromrey ML; Hasan M; Koziolek M; Tzvetkov MV; Weitschies W
    Mol Pharm; 2019 Apr; 16(4):1782-1786. PubMed ID: 30821987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota-triggered colonic delivery: robustness of the polysaccharide approach in the fed state in man.
    Basit AW; Short MD; McConnell EL
    J Drug Target; 2009 Jan; 17(1):64-71. PubMed ID: 19016069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone.
    Thombre AG; Shamblin SL; Malhotra BK; Connor AL; Wilding IR; Caldwell WB
    J Control Release; 2015 Sep; 213():10-17. PubMed ID: 26130417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man.
    McConnell EL; Short MD; Basit AW
    J Control Release; 2008 Sep; 130(2):154-60. PubMed ID: 18639950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of guar gum-based colon-targeted oral drug delivery systems of metronidazole in healthy volunteers.
    Krishnaiah YS; Veer Raju P; Dinesh Kumar B; Jayaram B; Rama B; Raju V; Bhaskar P
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):287-94. PubMed ID: 14743970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.